– Anticipates Not Less Than 50% Rise in Consolidated Profit Attributable to Shareholders JBM (Healthcare) Limited (JBM Healthcare or the…
Browsing: Pharma
Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on…
Public Offering of 54.22 Million Issue Shares for Listing on the ACE Market of Bursa Malaysia TOPVISION Eye Specialist Berhad (“TOPVISION”…
– Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients Everest Medicines (HKG: 1952, Everest, or the…
The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li,…
– Demonstrating Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the…
HK equity market experienced snap adjustment rally in September, and is now entering stock picking phase before new round of…
Empowering Women and Their Health in the Workplace at GJK Facility Services In recognition of Breast Cancer Awareness Week, George…
Enhancing the Quality of Life for All, Commiting to Investing in Technology Upgrades, and Developing Pharmaceutical and Healthcare Product Innovations…
– Published in “Kidney 360” Magazine Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the…
– ACROMETA seeks to unlock value from its disposal of Life Science Incubator Holdings Pte. Ltd. following a strategic review.…
Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
Everest Medicines (HKG: 1952) closed today with a 20.46% increase, hitting a high of HKD 28.6. The company’s stock price…
According to Ageas’s press release, BNP Paribas notified Ageas on October 3, 2024, that its current shareholding in Ageas reached…
As we enter the fourth quarter, the market buzzes with optimism. The U.S. Federal Reserve’s interest rate reduction, aimed at…
– VLP-Polio Expected to Accelerate Development and Fill the Gap. CanSino Biologics Inc. (CanSinoBIO or the Company) has announced a…
People often associate the matters of the heart with emotional experiences, but heart health is a critical aspect that often…
– and with 2024 1H Performance Growing Strongly – Everest Medicines Showcasing its Industry LeadershipRecently, Everest Medicines has announced another positive development.…
Supporting patient comfort, improved diagnostics, and streamlined workflow, available in Europe, parts of Asia and Oceania Olympus Corporation (Olympus), a…
GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating…